◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › TRLV

Trulieve Cannabis Corp. (TRLV) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-07-10

Trulieve Cannabis Corp. (TRLV) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Tallahassee, United States with about 5,000 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, TRLV reported $1.2B in revenue and ($116M) in net income.

Trulieve Cannabis Corp. operates as a cannabis retailer in the United States. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery.

Interactive charts & full statements → Open the TRLV valuation workbench →

TRLV Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$1.2B$1.2B$1.1B$1.2B
Gross Profit$711M$716M$589M$689M
Operating Income (EBIT)$148M$92M$93M$126M
Net Income($116M)($155M)($527M)($246M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

TRLV Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Revenue$287M$293M$288M$302M$298M
Gross Profit$170M$175M$170M$183M$183M
Operating Income (EBIT)$35M$19M$41M$52M$35M
Net Income$2M($43M)($27M)($14M)($33M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

TRLV Free Cash Flow History

Cash flow2025-12-312024-12-312023-12-312022-12-312021-12-31
Dividends Paid($0M)($0M)$0M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

TRLV Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$2.7B$2.9B$2.7B$3.4B
Total Liabilities$1.6B$1.6B$1.3B$1.5B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive TRLV viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

← TRIPAll stocksTRMB →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.